| UCB-Pharma SA - Vimpat 50 mg, comprimés pelliculés | | 59002 | | 01 | | Vimpat 50 mg | | comprimés pelliculés | | N03AX18 | | Lacosamide | | 28.08.2009 | | |
| | Zusammensetzung | | lacosamidum 50 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, cellulosum microcristallinum silicificatum, crospovidonum, magnesii stearas, hydroxypropylcellulosum, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, E 132, E 171, E 172 (rubrum), E 172 (nigrum) pro compresso obducto. | | Packungsbestandteile | | Filmtabletten | | | | | Wirkstoffe | Stärke |
|---|
| Lacosamidum | 50 mg |
| | BAG: Wirkstoffe | Stärke |
|---|
| Lacosamidum | 50 mg |
| | | | Hilfsstoffe | Stärke | Zusätzliche Information |
|---|
| (Nigrum) pro Compresso Obducto | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | Cellulosum Microcristallinum Silicificatum | | | | Crospovidonum | | | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hydroxypropylcellulosum Substitutum Humile | | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | pellicule | | Talcum | | |
| |
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| 001 | 14 Tablette(n) | 5.45 | 15.15 | B | SL | Ja |
|
|
